Your browser doesn't support javascript.
loading
Radiation Therapy in Non-Melanoma Skin Cancers: An Italian Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology.
Pezzulla, D; Pastore, F; Fionda, B; Cellini, F; Di Franco, R; Ciabattoni, A; Corazzi, F; Cossa, S; Dominici, L; Draghini, L; Gherardi, F; Lillo, S; Longo, S; Mazzarotto, R; Navarria, F; Piccolo, F; Stefanelli, A; Vicenzi, L; Zamagni, A; Maranzano, E; Tagliaferri, L.
Afiliação
  • Pezzulla D; Radiation Oncology Unit, Responsible Research Hospital, Italy.
  • Pastore F; Dipartimento di Diagnostica Per Immagini, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Radioterapia Oncologica ed Ematologia, Italy.
  • Fionda B; Dipartimento di Diagnostica Per Immagini, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Radioterapia Oncologica ed Ematologia, Italy. Electronic address: bruno.fionda@policlinicogemelli.it.
  • Cellini F; Dipartimento di Diagnostica Per Immagini, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Radioterapia Oncologica ed Ematologia, Italy.
  • Di Franco R; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Italy.
  • Ciabattoni A; UOC Radioterapia, Ospedale San Filippo Neri, ASL Roma 1, Italy.
  • Corazzi F; S.C. Radioterapia aziendale USL Umbria1 Ospedale Città di Castello (PG), Italy.
  • Cossa S; UOC Radioterapia, Fondazione "Casa Sollievo della Sofferenza," IRCCS, S. Giovanni Rotondo, Foggia, Italy.
  • Dominici L; Department of Radiotherapy, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.
  • Draghini L; Radiation Oncology Centre, S Maria Hospital, Terni, Italy.
  • Gherardi F; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Italy.
  • Lillo S; Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Longo S; Dipartimento di Diagnostica Per Immagini, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Radioterapia Oncologica ed Ematologia, Italy.
  • Mazzarotto R; Radiation Oncology Unit, Azienda Ospedaliera Universitaria Integrata, 37124 Verona, Italy.
  • Navarria F; Radiation Oncology Department, National Cancer Institute (CRO)- IRCCS, Aviano, Italy.
  • Piccolo F; SC di Radioterapia Ospedale di Circolo Fondazione Macchi, Varese, Italy.
  • Stefanelli A; Operational Unit of Oncological Radiotherapy, St Anna University Hospital of Ferrara, Italy.
  • Vicenzi L; Radiation Oncology, Fondazione Policlinico Universitario Campus Biomedico, Italy.
  • Zamagni A; Radiation Oncology, Department of Experimental Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum-Bologna University, Italy.
  • Maranzano E; Former Full Professor of Radiation Oncology, University of Perugia, Italy.
  • Tagliaferri L; Dipartimento di Diagnostica Per Immagini, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Radioterapia Oncologica ed Ematologia, Italy.
Article em En | MEDLINE | ID: mdl-38971685
ABSTRACT

AIMS:

The National Palliative Care and Interventional Radiotherapy Study Groups of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) carried out a survey whose aim was to obtain a "snapshot" of the real-world practice of nonmelanoma skin cancer (NMSC) treatments in Italy. MATERIALS AND

METHODS:

The survey was conducted on SurveyMonkey's online interface and was sent via e-mail to our society Radiation Oncologists.

RESULTS:

Fifty-eight Italian radiation oncologists (ROs), representing 54 centers, answered the survey. Thirteen percent of the ROs declared they treat fewer than 10 NMSC lesions annually, 36% treat between 11 and 20, and 51% treat more than 20 lesions annually. Interventional radiotherapy (IRT) was offered by 25% of the ROs, and every case was reportedly discussed by a multidisciplinary team (71%). Electrons (74%), volumetric modulated arc therapy (V-MAT) (57%), three-dimensional conformal radiotherapy (3D-CRT) (43%), and IRT (26%) were the main treatment options. With external beam radiotherapy (EBRT), 46 and 53 different RT schedules were treated for curative and palliative intent, respectively; whereas for IRT, there were 21 and 7 for curative and palliative intent, respectively. The most popular EBRT curative options were 50-70.95/22-35 fractions (fx) and 50-70 Gy/16-20fx and for EBRT palliative settings, 30Gy/10fx, and 20-35Gy/5fx. For IRT, the most popular curative options were 32-50Gy/8-10fx and 30-54Gy/3-5fx, whereas 30Gy/6fz was the palliative option. Less than 10 re-RT cases were reported in one year in 42.5%, 11-20 cases in 42.5%, and >20 cases annually in 15%. Electrons (61%), VMAT (49%), and BRT (25%) were the most widely used approaches 20-40Gy in 10fx and 20-25Gy in 5fx were the recommended fractionations.

CONCLUSION:

The survey shows a variegated reality. A national registry with more detailed data could help in undercover its causes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália